Referencias del cáncer de vesícula biliar

Abou-Alfa GK, Jarnagin W, Lowery M, et al. Chapter 80: Liver and bile duct cancer. In: Niederhuber JE, Armitage JO, Dorshow JH, Kastan MB, Tepper JE, eds. Abeloff’s Clinical Oncology. 5th ed. Philadelphia, Pa. Elsevier: 2014.

American Cancer Society. Cancer Facts & Figures 2016. Atlanta, Ga: American Cancer Society; 2016.

American Cancer Society. Cancer Facts & Figures 2017. Atlanta, Ga: American Cancer Society; 2017.

American Joint Committee on Cancer. Gallbladder. In: AJCC Cancer Staging Manual. 7^th ed. New York: Springer; 2010: 211-214.

Bartlett DL, Ramanathan RK, Ben-Josef E. Cancer of the biliary tree. In: DeVita VT, Lawrence TS, Rosenberg SA, eds. DeVita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology. 9^th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2011: 1019-1047.

Ciombor KK, Goff LW. Advances in the management of biliary tract cancers. Clin Adv Hematol Oncol. 2013;11:28-34.

Dixon E, Vollmer CM, Sahajpal A, et al. An aggressive surgical approach leads to improved survival in patients with gallbladder cancer. Ann Surgery. 2005;241:385-394.

Fong Y, Wagman L, Gonen M, et al. Evidence-based gallbladder cancer staging: Changing cancer staging by analysis of data from the National Cancer Database. Ann Surg. 2006;243:767-771.

Howlader N, Noone AM, Krapcho M, et al (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.

Lazcano-Ponce EC, Miquesl JF, Munoz N, et al. Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin. 2001;51:349-364.

Lewis JT, Talwalkar JA, Rosen CB, Smyrk TC, Abraham SC. Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: Evidence for a metaplasia-dysplasia-carcinoma sequence. Am J Surg Pathol. 2007;31(6):907-913.

Misra S, Chaturvedi A, Misra NC, et al. Carcinoma of the gallbladder. Lancet Oncology. 2003;4:167-176.

National Cancer Institute. Physician Data Query (PDQ). Gallbladder Cancer Treatment. 2014. Accessed at www.cancer.gov/cancertopics/pdq/treatment/gallbladder/HealthProfessional on September 4, 2014.

National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Hepatobiliary Cancers. V.2.2014. Accessed at www.nccn.org/professionals/physician_gls/pdf/hepatobiliary.pdf on September 4, 2014.

Rock CL, Thomson C, Gansler T, et al. American Cancer Society guideline for diet and physical activity for cancer prevention. CA: A Cancer Journal for Clinicians. 2020;70(4). doi:10.3322/caac.21591. Accessed at https://onlinelibrary.wiley.com/doi/full/10.3322/caac.21591 on June 9, 2020.

Valle J, Wasan H, Palmer DH, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362:1273-1281.

Wistuba II, Gazdar AF. Gallbladder cancer: Lessons from a rare tumor. Nature Reviews Cancer. 2004;4:695-706.